INDICATION: Rheumatoid arthritis (RA)
Patient sample and mouse studies suggest a hydrogel-based formulation of the GCCR agonist triamcinolone acetonide could help treat RA and other forms of inflammatory arthritis. The hydrogel contains injectable triglycerol monostearate that self-assembles into lamellar structures and is loaded with the corticosteroid triamcinolone...